The discovery of a molecular factor that triggers blood clots in lung arteries may explain why chronic thromboembolic pulmonary hypertension (CTEPH) often occurs in patients without traditional clotting risk factors, according to a study. Researchers think the factor, called activated TAFI, could be used to identify those with CTEPH. And…

https://vimeo.com/184579437 In this video from Elsevier Pharma Solutions, Professor Marc Humbert discusses the diagnostic processes for pulmonary hypertension and chronic thromboembolic pulmonary hypertension (CTEPH)—which is a curable form of the disease. RELATED: A study find international diagnosis and management of CTEPH is inadequate. Prof. Hubert explains that CTEPH is…

When people talk about pulmonary hypertension (PH), they’re talking about a condition where high blood pressure in the lungs leads to the narrowing of the blood vessels to the heart, causing the right side of the heart to work much harder to pump oxygenated blood back into the lungs. This can then lead…

The Pulmonary Hypertension Association (PHA) will present two abstracts with data from the PHA registry, which collects information on pulmonary hypertension (PH) patients diagnosed and evaluated at PHA-accredited centers with the goal of improving their care. The presentations will be given at the American Thoracic Society meeting set for May.

Bayer and Merck recently presented positive results from five data sets that evaluated the clinical benefits of Adempas (riociguat) for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). The findings were presented at the 11th annual World Congress of the Pulmonary Vascular…

Inhalation treatment that uses either nitric oxide or Ventavis (iloprost) is equally effective in managing lingering high lung blood pressure after surgery for chronic thromboembolic pulmonary hypertension (CTEPH). A comparison of the two treatments — published in the journal General Thoracic and Cardiovascular Surgery under the title, “A prospective, randomized study…

A team of researchers at Columbia University Medical Center and New York Presbyterian Hospital advise patients with pulmonary hypertension no to become pregnant, based on the case of a 28-year-old woman who was diagnosed with chronic thromboembolic pulmonary hypertension (CTEPH), or group 4 pulmonary hypertension, during her pregnancy.

The Pulmonary Hypertension Association (PHA) is planning a series of events for November, Pulmonary Hypertension Awareness Month, including a daylong focus on chronic thromboembolic pulmonary hypertension (CTEPH), a form of pulmonary hypertension (PH) that results from blood clots in the lungs. Events planned for CTEPH Awareness Day, Nov. 15, include promoting information about the two…

Pulmonary hypertension (PH) is a rare lung disease characterized by increased blood pressure in the pulmonary arteries.  These are the arteries that carry deoxygenated blood from a person’s heart to the lungs to pick up oxygen. As the pressure builds, the heart must work harder to pump blood through the lungs. Over…

An electronic nose, or “e-nose,” that can detect the presence of pulmonary arterial hypertension (PAH) was created by researchers at the Université Paris-Saclay in partnership with the Technion Israel Institute of Technology. The e-nose device makes use of the fact that PAH has a marked olfactory signature, with a specific…

The presence of atrial arrhythmias may help predict unfavorable prognosis in patients with pulmonary hypertension (PH), according to a study published in the Cardiology Journal. The study also showed that longer P-waves, a type of wave found in electrocardiographies (ECG), can predict shorter survival rates. The work was developed…

Results from a retrospective study based on a claims database of U.S. patients with pulmonary embolism indicated that physicians are failing to recognize and diagnose thousands of cases of the serious lung disease, chronic thromboembolic pulmonary hypertension (CTEPH). The study, “Monitoring for Pulmonary…